NRSN Insider Trading Activity and SEC Form 4 Filings
NRSN insider trading summary
Over the past 12 months, insiders at NeuroSense Therapeutics Ltd. (NRSN) reported 2 open-market purchases worth $400K by 2 insiders and no sales on SEC Form 4. Net insider buying was $400K.
Latest NRSN insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Jun 16, 2026 | Alon Ben-Noon | Chief Executive Officer | Buy | $200K (250,000 @ $0.80) |
| Jun 16, 2026 | Or Eisenberg | Chief Financial Officer | Buy | $200K (250,000 @ $0.80) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.